Dr. Meghana Prabhu S

Dr. Meghana Prabhu S

Consultant & Associate Professor
MBBS, DNB (Nuclear Medicine), DM (Therapeutic Nuclear Medicine, AIIMS, New Delhi), MNAMS, Fellow of the Asian Nuclear Medicine Board (FANMB)
Speciality: Nuclear Medicine
Book an Appointment
Overview
Area of Expertise
Qualification
Languages Known
Work Experience
Awards and Recognition
Publications

Dr. Meghana Prabhu S, is amongst the few DM Therapeutic Nuclear Medicine trained doctors in the country (trained from the prestigious AIIMS, New Delhi). Dr. Prabhu is an avid researcher with over 24 publications, has authored book chapters and is a reviewer for many international journals. Her areas of interest include Nuclear Oncology and Theranostics in Nuclear Medicine & its application in treating prostate cancer, neuroendocrine cancer, thyroid cancer, targeted alpha therapy, etc. Previously she has served as Assistant Professor, Nuclear Medicine in ILBS, New Delhi (2020-2022). Dr. Prabhu has presented several papers in various conferences and CMEs.

  • General Nuclear Medicine Imaging
  • PET – CT imaging, Nuclear Oncology
  • Theranostics related to Prostate Cancer, Neuroendocrine Cancer, Thyroid Cancer, Pheochromocytoma / Paraganglioma; SIRT, Targeted Alpha Therapeutics.
  • MBBS

  • DNB (Nuclear Medicine)

  • DM (Therapeutic Nuclear Medicine)

    AIIMS, New Delhi (2020)

  • MNAMS

  • FANMB

    Fellow of the Asian Nuclear Medicine Board

  • English
  • Hindi
  • 2020

    Assistant Professor

    Department of Nuclear Medicine, Institute of Liver and Biliary Sciences, New Delhi (Aug 2020 - Aug 2022)

  • 2017

    DM (Therapeutic Nuclear Medicine)

    All India Institute of Medical Sciences, New Delhi. (Jan 2017 – Jan 2020)

  • 2016

    Junior Consultant

    Department of Nuclear Medicine, Narayana Health City, Bengaluru. (June 2016 - Dec 2016)

  • Awarded first place for oral paper presentation in National Cardiology Society of India Biennial Conference 2013, Chennai. 
  • Received Gold Medal, DNB from National Board of Examinations in 2018.
  • Awarded Fellow of Asian Board of Nuclear Medicine, 2019 held at AOCNMB, Shanghai, China.
  • RCA award for presentation at the 2021 annual general meeting of ARCCNM.
  • Total: 24 (both international and National)

Dr. Meghana Prabhu S, is amongst the few DM Therapeutic Nuclear Medicine trained doctors in the country (trained from the prestigious AIIMS, New Delhi). Dr. Prabhu is an avid researcher with over 24 publications, has authored book chapters and is a reviewer for many international journals. Her areas of interest include Nuclear Oncology and Theranostics in Nuclear Medicine & its application in treating prostate cancer, neuroendocrine cancer, thyroid cancer, targeted alpha therapy, etc. Previously she has served as Assistant Professor, Nuclear Medicine in ILBS, New Delhi (2020-2022). Dr. Prabhu has presented several papers in various conferences and CMEs.

  • General Nuclear Medicine Imaging
  • PET – CT imaging, Nuclear Oncology
  • Theranostics related to Prostate Cancer, Neuroendocrine Cancer, Thyroid Cancer, Pheochromocytoma / Paraganglioma; SIRT, Targeted Alpha Therapeutics.

  • MBBS

  • DNB (Nuclear Medicine)

  • DM (Therapeutic Nuclear Medicine)

    AIIMS, New Delhi (2020)

  • MNAMS

  • FANMB

    Fellow of the Asian Nuclear Medicine Board

  • English
  • Hindi

  • 2020

    Assistant Professor

    Department of Nuclear Medicine, Institute of Liver and Biliary Sciences, New Delhi (Aug 2020 - Aug 2022)

  • 2017

    DM (Therapeutic Nuclear Medicine)

    All India Institute of Medical Sciences, New Delhi. (Jan 2017 – Jan 2020)

  • 2016

    Junior Consultant

    Department of Nuclear Medicine, Narayana Health City, Bengaluru. (June 2016 - Dec 2016)

  • Awarded first place for oral paper presentation in National Cardiology Society of India Biennial Conference 2013, Chennai. 
  • Received Gold Medal, DNB from National Board of Examinations in 2018.
  • Awarded Fellow of Asian Board of Nuclear Medicine, 2019 held at AOCNMB, Shanghai, China.
  • RCA award for presentation at the 2021 annual general meeting of ARCCNM.

  • Total: 24 (both international and National)

Other Doctors

Dr. Abhishek Behera
Consultant
MD (Nuclear Medicine), DM (Therapeutic Nuclear Medicine)